Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1108

1.

A horizon scan of priorities for coastal marine microbiome research.

Trevathan-Tackett SM, Sherman CDH, Huggett MJ, Campbell AH, Laverock B, Hurtado-McCormick V, Seymour JR, Firl A, Messer LF, Ainsworth TD, Negandhi KL, Daffonchio D, Egan S, Engelen AH, Fusi M, Thomas T, Vann L, Hernandez-Agreda A, Gan HM, Marzinelli EM, Steinberg PD, Hardtke L, Macreadie PI.

Nat Ecol Evol. 2019 Oct 21. doi: 10.1038/s41559-019-0999-7. [Epub ahead of print] Review.

PMID:
31636428
2.

Urban beaches are environmental hotspots for antibiotic resistance following rainfall.

Carney RL, Labbate M, Siboni N, Tagg KA, Mitrovic SM, Seymour JR.

Water Res. 2019 Dec 15;167:115081. doi: 10.1016/j.watres.2019.115081. Epub 2019 Sep 12.

PMID:
31574348
3.

Accounts from developers of generic health state utility instruments explain why they produce different QALYs: A qualitative study.

Pickles K, Lancsar E, Seymour J, Parkin D, Donaldson C, Carter SM.

Soc Sci Med. 2019 Nov;240:112560. doi: 10.1016/j.socscimed.2019.112560. Epub 2019 Sep 19.

4.

Ultracompliant Carbon Nanotube Direct Bladder Device.

Yan D, Bruns TM, Wu Y, Zimmerman LL, Stephan C, Cameron AP, Yoon E, Seymour JP.

Adv Healthc Mater. 2019 Sep 25:e1900477. doi: 10.1002/adhm.201900477. [Epub ahead of print]

PMID:
31556241
5.

Exposure-response analysis of venetoclax in combination with rituximab in patients with relapsed or refractory chronic lymphocytic leukemia: pooled results from a phase 1b study and the phase 3 MURANO study.

Deng R, Gibiansky L, Lu T, Li X, Lu D, Li C, Girish S, Wang J, Boyer M, Shankar N, Humphrey K, Freise KJ, Salem AH, Seymour JF, Kater AP, Miles D.

Leuk Lymphoma. 2019 Sep 24:1-10. doi: 10.1080/10428194.2019.1657575. [Epub ahead of print]

PMID:
31549889
6.

Trace biomarkers associated with spontaneous preterm birth from the maternal serum metabolome of asymptomatic nulliparous women - parallel case-control studies from the SCOPE cohort.

Souza RT, McKenzie EJ, Jones B, de Seymour JV, Thomas MM, Zarate E, Han TL, McCowan L, Sulek K, Villas-Boas S, Kenny LC, Cecatti JG, Baker PN.

Sci Rep. 2019 Sep 23;9(1):13701. doi: 10.1038/s41598-019-50252-7.

7.

A two-region transport model for interpreting T1-T2 measurements in complex systems.

Maneval JE, Nelson ML, Thrane LW, Codd SL, Seymour JD.

J Magn Reson. 2019 Sep 6;308:106592. doi: 10.1016/j.jmr.2019.106592. [Epub ahead of print]

PMID:
31542448
8.

Venetoclax, the first BCL-2 inhibitor for use in patients with chronic lymphocytic leukemia.

Seymour J.

Clin Adv Hematol Oncol. 2019 Aug;17(8):440-443. No abstract available.

PMID:
31449511
9.

Non-invasive imaging of oxygen concentration in a complex in vitro biofilm infection model using 19 F MRI: Persistence of an oxygen sink despite prolonged antibiotic therapy.

Simkins JW, Stewart PS, Codd SL, Seymour JD.

Magn Reson Med. 2019 Dec;82(6):2248-2256. doi: 10.1002/mrm.27888. Epub 2019 Aug 2.

PMID:
31373035
10.

A Retrospective Evaluation of Risk of Peripartum Cardiac Dysfunction in Survivors of Childhood, Adolescent and Young Adult Malignancies.

Chait-Rubinek L, Mariani JA, Goroncy N, Herschtal A, Wheeler GC, Dwyer MK, Seymour JF, Campbell BA.

Cancers (Basel). 2019 Jul 24;11(8). pii: E1046. doi: 10.3390/cancers11081046.

11.

Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL.

Tam CS, Trotman J, Opat S, Burger JA, Cull G, Gottlieb D, Harrup R, Johnston PB, Marlton P, Munoz J, Seymour JF, Simpson D, Tedeschi A, Elstrom R, Yu Y, Tang Z, Han L, Huang J, Novotny W, Wang L, Roberts AW.

Blood. 2019 Sep 12;134(11):851-859. doi: 10.1182/blood.2019001160. Epub 2019 Jul 24.

12.

Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study.

Bachy E, Seymour JF, Feugier P, Offner F, López-Guillermo A, Belada D, Xerri L, Catalano JV, Brice P, Lemonnier F, Martin A, Casasnovas O, Pedersen LM, Dorvaux V, Simpson D, Leppa S, Gabarre J, da Silva MG, Glaisner S, Ysebaert L, Vekhoff A, Intragumtornchai T, Le Gouill S, Lister A, Estell JA, Milone G, Sonet A, Farhi J, Zeuner H, Tilly H, Salles G.

J Clin Oncol. 2019 Jul 24:JCO1901073. doi: 10.1200/JCO.19.01073. [Epub ahead of print]

PMID:
31339826
13.

Medication Abortion Provided Through Telemedicine in Four U.S. States.

Kohn JE, Snow JL, Simons HR, Seymour JW, Thompson TA, Grossman D.

Obstet Gynecol. 2019 Aug;134(2):343-350. doi: 10.1097/AOG.0000000000003357.

PMID:
31306317
14.

The Use of Optimal Treatment for DLBCL Is Improving in All Age Groups and Is a Key Factor in Overall Survival, but Non-Clinical Factors Influence Treatment.

Wong Doo N, White VM, Martin K, Bassett JK, Prince HM, Harrison SJ, Jefford M, Winship I, Millar JL, Milne RL, Seymour JF, Giles GG.

Cancers (Basel). 2019 Jul 2;11(7). pii: E928. doi: 10.3390/cancers11070928.

15.

High prevalence of antibiotic allergies in cladribine-treated patients with hairy cell leukemia - lessons for immunopathogenesis and prescribing.

Meher-Homji Z, Tam CS, Siderov J, Seymour JF, Holmes NE, Chua KYL, Phillips EJ, Slavin MA, Trubiano JA.

Leuk Lymphoma. 2019 Jul 1:1-6. doi: 10.1080/10428194.2019.1633640. [Epub ahead of print]

PMID:
31256738
16.

Establishing key criteria to define and compare models of specialist palliative care: A mixed-methods study using qualitative interviews and Delphi survey.

Firth AM, O'Brien SM, Guo P, Seymour J, Richardson H, Bridges C, Hocaoglu MB, Grande G, Dzingina M, Higginson IJ, Murtagh FE.

Palliat Med. 2019 Sep;33(8):1114-1124. doi: 10.1177/0269216319858237. Epub 2019 Jun 28.

17.

Patient and carer involvement in palliative care research: An integrative qualitative evidence synthesis review.

Chambers E, Gardiner C, Thompson J, Seymour J.

Palliat Med. 2019 Sep;33(8):969-984. doi: 10.1177/0269216319858247. Epub 2019 Jun 28.

18.

Characterization of a novel venetoclax resistance mutation (BCL2 Phe104Ile) observed in follicular lymphoma.

Blombery P, Birkinshaw RW, Nguyen T, Gong JN, Thompson ER, Xu Z, Westerman DA, Czabotar PE, Dickinson M, Huang DCS, Seymour JF, Roberts AW.

Br J Haematol. 2019 Sep;186(6):e188-e191. doi: 10.1111/bjh.16069. Epub 2019 Jun 24. No abstract available.

PMID:
31234236
19.

Bayesian Population Model of the Pharmacokinetics of Venetoclax in Combination with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Results from the Phase III MURANO Study.

Deng R, Gibiansky L, Lu T, Agarwal P, Ding H, Li X, Kshirsagar S, Lu D, Li C, Girish S, Wang J, Boyer M, Humphrey K, Freise KJ, Salem AH, Seymour JF, Kater AP, Miles D.

Clin Pharmacokinet. 2019 Jun 18. doi: 10.1007/s40262-019-00788-8. [Epub ahead of print]

PMID:
31209657
20.

Vulnerability of seagrass blue carbon to microbial attack following exposure to warming and oxygen.

Macreadie PI, Atwood TB, Seymour JR, Fontes MLS, Sanderman J, Nielsen DA, Connolly RM.

Sci Total Environ. 2019 Oct 10;686:264-275. doi: 10.1016/j.scitotenv.2019.05.462. Epub 2019 Jun 2.

PMID:
31181514
21.

Differential effects of BTK inhibitors ibrutinib and zanubrutinib on NK cell effector function in patients with mantle cell lymphoma.

Flinsenberg TWH, Tromedjo CC, Hu N, Liu Y, Guo Y, Thia KYT, Noori T, Song X, Aw Yeang HX, Tantalo DG, Handunnetti S, Seymour JF, Roberts AW, Ritchie D, Koldej R, Neeson PJ, Wang L, Trapani JA, Tam CS, Voskoboinik I.

Haematologica. 2019 Jun 6. pii: haematol.2019.220590. doi: 10.3324/haematol.2019.220590. [Epub ahead of print]

22.

Regional and Microenvironmental Scale Characterization of the Zostera muelleri Seagrass Microbiome.

Hurtado-McCormick V, Kahlke T, Petrou K, Jeffries T, Ralph PJ, Seymour JR.

Front Microbiol. 2019 May 14;10:1011. doi: 10.3389/fmicb.2019.01011. eCollection 2019.

23.

Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations.

Soumerai JD, Ni A, Darif M, Londhe A, Xing G, Mun Y, Kay NE, Shanafelt TD, Rabe KG, Byrd JC, Chanan-Khan AA, Furman RR, Hillmen P, Jones J, Seymour JF, Sharman JP, Ferrante L, Mobasher M, Stark T, Reddy V, Dreiling LK, Bhargava P, Howes A, James DF, Zelenetz AD.

Lancet Haematol. 2019 Jul;6(7):e366-e374. doi: 10.1016/S2352-3026(19)30085-7. Epub 2019 May 17. Erratum in: Lancet Haematol. 2019 Jul;6(7):e348.

PMID:
31109827
24.

Direct Synthesis of Multiplexed Metal-Nanowire-Based Devices by Using Carbon Nanotubes as Vector Templates.

Clément P, Xu X, Stoppiello CT, Rance GA, Attanzio A, O'Shea JN, Temperton RH, Khlobystov AN, Lovelock KRJ, Seymour JM, Fogarty RM, Baker A, Bourne RA, Hall B, Chamberlain TW, Palma M.

Angew Chem Int Ed Engl. 2019 Jul 15;58(29):9928-9932. doi: 10.1002/anie.201902857. Epub 2019 Jun 11.

PMID:
31059175
25.

An integrated understanding of the complex drivers of emergency presentations and admissions in cancer patients: Qualitative modelling of secondary-care health professionals' experiences and views.

Chen H, Walabyeki J, Johnson M, Boland E, Seymour J, Macleod U.

PLoS One. 2019 May 2;14(5):e0216430. doi: 10.1371/journal.pone.0216430. eCollection 2019.

26.

Molecular dissection of box jellyfish venom cytotoxicity highlights an effective venom antidote.

Lau MT, Manion J, Littleboy JB, Oyston L, Khuong TM, Wang QP, Nguyen DT, Hesselson D, Seymour JE, Neely GG.

Nat Commun. 2019 Apr 30;10(1):1655. doi: 10.1038/s41467-019-09681-1.

27.

REMOVED: Safety Is the Heart of the Matter.

Campbell BA, Seymour JF.

Int J Radiat Oncol Biol Phys. 2019 Apr 23. pii: S0360-3016(19)30248-2. doi: 10.1016/j.ijrobp.2019.02.022. [Epub ahead of print] No abstract available.

PMID:
31027909
28.

Efficacy of venetoclax in relapsed chronic lymphocytic leukemia is influenced by disease and response variables.

Roberts AW, Ma S, Kipps TJ, Coutre SE, Davids MS, Eichhorst B, Hallek M, Byrd JC, Humphrey K, Zhou L, Chyla B, Nielsen J, Potluri J, Kim SY, Verdugo M, Stilgenbauer S, Wierda WG, Seymour JF.

Blood. 2019 Jul 11;134(2):111-122. doi: 10.1182/blood.2018882555. Epub 2019 Apr 25.

PMID:
31023700
29.

Staff perception of obstacles and facilitators when providing end of life care in critical care units of two teaching hospitals: A survey design.

Almansour I, Seymour JE, Aubeeluck A.

Intensive Crit Care Nurs. 2019 Aug;53:8-14. doi: 10.1016/j.iccn.2019.04.003. Epub 2019 Apr 22.

PMID:
31023516
30.

The trials and tribulations of conducting an m-health pilot randomized controlled trial to improve oral cancer therapy adherence: recommendations for future multisite, non-drug clinical trials.

Russell L, Pascoe MC, Seymour JF, Aranda S, Butow P, Gough K, Schofield P.

BMC Res Notes. 2019 Apr 15;12(1):226. doi: 10.1186/s13104-019-4264-6.

31.

A multicenter retrospective comparison of induction chemoimmunotherapy regimens on outcomes in transplant-eligible patients with previously untreated mantle cell lymphoma.

Ng ZY, Bishton M, Ritchie D, Campbell R, Gilbertson M, Hill K, Ratnasingam S, Schwarer A, Manos K, Shorten S, Ng M, Nelson N, Xin L, De Mel Widanalage S, Sunny T, Purtill D, Poon M, Johnston A, Cochrane T, Lee HP, Hapgood G, Tam C, Opat S, Hawkes E, Seymour J, Cheah CY.

Hematol Oncol. 2019 Aug;37(3):253-260. doi: 10.1002/hon.2618. Epub 2019 May 24.

PMID:
30983008
32.

Probing diffusion dynamics during hydrate formation by high field NMR relaxometry and diffusometry.

Thrane LW, Seymour JD, Codd SL.

J Magn Reson. 2019 Jun;303:7-16. doi: 10.1016/j.jmr.2019.04.003. Epub 2019 Apr 4.

PMID:
30980965
33.

The role of microbial motility and chemotaxis in symbiosis.

Raina JB, Fernandez V, Lambert B, Stocker R, Seymour JR.

Nat Rev Microbiol. 2019 May;17(5):284-294. doi: 10.1038/s41579-019-0182-9. Review.

PMID:
30923350
34.

Variability in the Composition of Pacific Oyster Microbiomes Across Oyster Families Exhibiting Different Levels of Susceptibility to OsHV-1 μvar Disease.

King WL, Siboni N, Williams NLR, Kahlke T, Nguyen KV, Jenkins C, Dove M, O'Connor W, Seymour JR, Labbate M.

Front Microbiol. 2019 Mar 11;10:473. doi: 10.3389/fmicb.2019.00473. eCollection 2019.

35.

Role of obinutuzumab exposure on clinical outcome of follicular lymphoma treated with first-line immunochemotherapy.

Jamois C, Gibiansky E, Gibiansky L, Buchheit V, Sahin D, Cartron G, Marcus R, Hiddemann W, Seymour JF, Strefford JC, Hargreaves CE, Meneses-Lorente G, Frey N, Fingerle-Rowson G.

Br J Clin Pharmacol. 2019 Jul;85(7):1495-1506. doi: 10.1111/bcp.13920. Epub 2019 May 17.

36.

Better Sepsis Management Rather Than Fluoroquinolone Prophylaxis for Patients With Cancer-Related Immunosuppression.

Slavin MA, Worth LJ, Seymour JF, Thursky KA.

J Clin Oncol. 2019 May 1;37(13):1139-1140. doi: 10.1200/JCO.18.01474. Epub 2019 Mar 7. No abstract available.

PMID:
30844318
37.

Metabolomic biomarkers and novel dietary factors associated with gestational diabetes in China.

Chen X, de Seymour JV, Han TL, Xia Y, Chen C, Zhang T, Zhang H, Baker PN.

Metabolomics. 2018 Nov 3;14(11):149. doi: 10.1007/s11306-018-1445-6.

PMID:
30830425
38.

Metabolomic profiling of maternal hair suggests rapid development of intrahepatic cholestasis of pregnancy.

de Seymour JV, Tu S, He X, Zhang H, Han TL, Baker PN, Sulek K.

Metabolomics. 2018 May 26;14(6):79. doi: 10.1007/s11306-018-1371-7.

PMID:
30830343
39.

Glass Dynamics and Domain Size in a Solvent-Polymer Weak Gel Measured by Multidimensional Magnetic Resonance Relaxometry and Diffusometry.

Williamson NH, Dower AM, Codd SL, Broadbent AL, Gross D, Seymour JD.

Phys Rev Lett. 2019 Feb 15;122(6):068001. doi: 10.1103/PhysRevLett.122.068001.

40.
41.

Dual color optogenetic control of neural populations using low-noise, multishank optoelectrodes.

Kampasi K, English DF, Seymour J, Stark E, McKenzie S, Vöröslakos M, Buzsáki G, Wise KD, Yoon E.

Microsyst Nanoeng. 2018;4. pii: 10. doi: 10.1038/s41378-018-0009-2. Epub 2018 Jun 4.

42.

Unicellular Cyanobacteria Are Important Components of Phytoplankton Communities in Australia's Northern Oceanic Ecoregions.

Moore LR, Huang T, Ostrowski M, Mazard S, Kumar SS, Gamage HKAH, Brown MV, Messer LF, Seymour JR, Paulsen IT.

Front Microbiol. 2019 Jan 23;9:3356. doi: 10.3389/fmicb.2018.03356. eCollection 2018.

43.

Stormwater influences phytoplankton assemblages within the diverse, but impacted Sydney Harbour estuary.

Varkey D, Mazard S, Jeffries TC, Hughes DJ, Seymour J, Paulsen IT, Ostrowski M.

PLoS One. 2018 Dec 26;13(12):e0209857. doi: 10.1371/journal.pone.0209857. eCollection 2018.

44.

The Practice of Mutual Protection in the Care of Children with Palliative Care Needs: A Multiple Qualitative Case Study Approach from Jordan.

Atout M, Hemingway P, Seymour J.

J Pediatr Nurs. 2019 Mar - Apr;45:e9-e18. doi: 10.1016/j.pedn.2018.12.004. Epub 2018 Dec 19.

PMID:
30579650
45.

Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression.

Seymour JF, Marcus R, Davies A, Gallop-Evans E, Grigg A, Haynes A, Herold M, Illmer T, Nilsson-Ehle H, Sökler M, Dünzinger U, Nielsen T, Launonen A, Hiddemann W.

Haematologica. 2019 Jun;104(6):1202-1208. doi: 10.3324/haematol.2018.209015. Epub 2018 Dec 20.

46.

A phase II study of a modified hyper-CVAD frontline therapy for patients with adverse risk diffuse large B-cell and peripheral T-cell non-Hodgkin lymphoma.

Hapgood G, Stone JM, Zannino D, George A, Marlton P, Prince HM, Hui CH, Prosser I, Lewis ID, Bradstock K, Seymour JF; Australasian Leukaemia and Lymphoma Group.

Leuk Lymphoma. 2019 Apr;60(4):904-911. doi: 10.1080/10428194.2018.1516873. Epub 2018 Dec 14.

PMID:
30547695
47.

Azacitidine with or without lenalidomide in higher risk myelodysplastic syndrome & low blast acute myeloid leukemia.

Kenealy M, Hertzberg M, Benson W, Taylor K, Cunningham I, Stevenson W, Hiwase D, Eek R, Zantomio D, Jong S, Wall M, Blombery P, Gerber T, Debrincat M, Zannino D, Seymour JF.

Haematologica. 2019 Apr;104(4):700-709. doi: 10.3324/haematol.2018.201152. Epub 2018 Dec 13.

48.

Fixed Duration of Venetoclax-Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia Eradicates Minimal Residual Disease and Prolongs Survival: Post-Treatment Follow-Up of the MURANO Phase III Study.

Kater AP, Seymour JF, Hillmen P, Eichhorst B, Langerak AW, Owen C, Verdugo M, Wu J, Punnoose EA, Jiang Y, Wang J, Boyer M, Humphrey K, Mobasher M, Kipps TJ.

J Clin Oncol. 2019 Feb 1;37(4):269-277. doi: 10.1200/JCO.18.01580. Epub 2018 Dec 3.

49.

Quantifying Inorganic Nitrogen Assimilation by Synechococcus Using Bulk and Single-Cell Mass Spectrometry: A Comparative Study.

Giardina M, Cheong S, Marjo CE, Clode PL, Guagliardo P, Pickford R, Pernice M, Seymour JR, Raina JB.

Front Microbiol. 2018 Nov 27;9:2847. doi: 10.3389/fmicb.2018.02847. eCollection 2018.

50.

Facilitators and Barriers to Contraceptive Use Among U.S. Servicewomen Who Had an Abortion.

Seymour JW, Fix L, Grossman D, Grindlay K.

Mil Med. 2019 May 1;184(5-6):e417-e423. doi: 10.1093/milmed/usy340.

PMID:
30535236

Supplemental Content

Loading ...
Support Center